Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Clinical Decision Support System Market by Type, Function, Indication, End User - Global Forecast to 2031

globenewswire.com
ORCL Mentioned as a key player in the clinical decision support systems market, indicating its involvement in a growing sector. No specific positive or negative performance is detailed. ASO Mentioned as a key player in the clinical decision support systems market, indicating its involvement in a growing sector. No specific positive or negative performance is detailed. RHP Mentioned as a key player in the clinical decision support systems market, indicating its involvement in a growing sector. No specific positive or negative performance is detailed. KRP Mentioned as a participant in the clinical decision support systems market. The article does not provide specific sentiment towards the company's performance or outlook.

Clinical Decision Support System Market by Type, Function, Indication, End User - Global Forecast to 2031 Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Clinical Decision Support System Market by Type, Function, Indication, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The global clinical decision support systems (CDSS) market is projected to grow from USD 5.80 billion in 2026 to USD 10.15 billion by 2031, representing a compound annual growth rate (CAGR) of 11.8% during the forecast period. Increasing integration of CDSS platforms with electronic health records (EHRs), computerized physician order entry (CPOE) systems and AI-enabled healthcare workflows is accelerating adoption across healthcare organizations worldwide.

Demand for advanced clinical decision support systems is being driven by the need to reduce medication errors, improve clinical efficiency, support evidence-based care and enhance patient safety. Artificial intelligence, predictive analytics, natural language processing (NLP) and cloud-connected healthcare technologies are expanding CDSS capabilities, while government initiatives focused on healthcare digitization, interoperability and value-based care are strengthening demand for real-time, interoperable solutions.

Investments in healthcare IT modernization, connected care ecosystems and enterprise clinical intelligence platforms are also expected to support sustained CDSS market growth. However, data security concerns, integration complexity, high implementation costs for enterprise platforms and a shortage of healthcare professionals with AI expertise remain important market constraints.

Hospitals and Integrated Health Systems Lead End-User Growth

By end user, the market includes hospitals and integrated health systems, physician and specialty practices, ambulatory care centers and other end users. Hospitals and integrated health systems are expected to remain the largest and fastest-growing segment through 2031.

Healthcare institutions are incorporating CDSS platforms into clinician workflows, medication management, diagnostic processes and patient monitoring systems to improve treatment accuracy, reduce clinical variation and strengthen patient safety. Rising hospital admissions, increasing prevalence of complex diseases and pressure to improve operational efficiency are supporting deployment across hospital networks.

The expansion of interoperable EHRs, cloud-enabled infrastructure and AI-assisted clinical applications further reinforces the segment's position. Providers are investing in predictive clinical intelligence, workflow automation and real-time care coordination to advance evidence-based care and enterprise-wide healthcare optimization.

Cloud-Based CDSS Solutions Register the Fastest Growth

By deployment model, the CDSS market is segmented into cloud-based and on-premises solutions. Cloud-based CDSS platforms are projected to record the highest growth during the forecast period as healthcare providers prioritize scalable, accessible and interoperable technologies.

Cloud-enabled clinical platforms support real-time data exchange, enterprise-wide care coordination, AI-assisted decision-making and integration with EHRs and broader digital health ecosystems. Centralized data management, flexible infrastructure, lower initial deployment costs and faster software updates are encouraging adoption across hospitals, ambulatory care centers and multi-site healthcare networks.

Growth in telehealth, connected care, remote patient monitoring and AI-driven healthcare applications is also increasing demand for cloud-native decision support. Continued investment in healthcare cloud infrastructure is expected to create opportunities for vendors offering secure, interoperable and scalable CDSS technologies.

Asia Pacific Projected to Record the Highest CAGR

The market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is expected to register the highest CAGR, supported by rapid digital health infrastructure development, implementation of interoperable health information systems and increasing adoption of AI technologies.

Healthcare organizations in India, China, Japan, South Korea, Singapore and Indonesia are modernizing clinical environments through cloud-powered healthcare platforms, EHR systems and AI-supported clinical solutions. Rising chronic disease prevalence, expanding patient populations and demand for evidence-based workflows are further accelerating adoption across regional hospitals and healthcare networks.

National digital health and interoperability initiatives are strengthening connected care delivery and longitudinal patient data management. In May 2026, India's Ayushman Bharat Digital Mission reported that more than 100 crore health records had been linked to Ayushman Bharat Health Account accounts, demonstrating substantial progress in interoperable healthcare infrastructure and digital patient record integration.

Competitive Landscape and Research Coverage

Key clinical decision support systems market players include Wolters Kluwer, Epic Systems, Oracle Health, Optum, Merative, Veradigm LLC and Athenahealth, Inc. The competitive assessment also covers Elsevier, Zynx Health, Koninklijke Philips N.V. and Medical Information Technology, Inc. (MEDITECH), among other participants. Analysis includes company profiles, market share, product and service offerings, recent developments, investments and growth strategies.

The research evaluates the CDSS market by component, type, technology, deployment, function, indication, end user and region. It also examines emerging technologies, research and development activity, new product and service launches, untapped geographies and market diversification opportunities.

Primary research included interviews with CEOs, directors and other executives from key organizations. The respondent distribution was:

Key CDSS Market Opportunities and Challenges

The report provides market leaders and new entrants with revenue estimates for the CDSS market and its subsegments. It supports competitive positioning, go-to-market planning and strategic investment decisions while providing detailed insights into market drivers, restraints, opportunities, challenges and regional growth prospects.

Key Attributes:

Key Topics Covered:

Market Dynamics

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/lpymk8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.